Phoenix, Arizona (UroToday.com) At the meeting titled "The Interval of Fasting, Metabolism, and Cancer Risk," Dr. Marinac the cl...


He went on to discuss the Healthy Life and Feeding Study for Women, which was a randomized controlled intervention trial with 3,088 breast cancer survivors. Patients were followed longitudinally and the measurements repeated at the beginning of the study, 1 and 4 years. The evaluated clinical endpoints were breast cancer events (7.3 years follow-up) and mortality (cancer-specific and general).
- Overnight Lenten times were estimated based on nutritional reminders with timestamps.
- The recurrence of breast cancer was significantly lower in patients with nocturnal fasting> = 13 hours compared to <13 hours
- HR for specific survival of breast cancer (nocturnal fasting> = 13 hours vs. <13 hours): HR 1.21, p = 0.19
- There was also no difference in overall mortality

After 1 month, they found the following results:

Although it is not expected (and this is not explained as a potential benefit for the patients), they found a 1 kg weight loss in one month, regardless of race. The average nocturnal fast was 13-13.2 hours, based on 10.6-10.8 hours. There was no difference depending on the breed.
More important:
- 90% said fasting was easy.
- 90% said they could fast for more than 12 hours.
- 70% say that they prefer SMS over phone calls.
- 90% found the fast something pleasant
Takeaway statement: Prolonged nocturnal fasting may be a strategy to reduce cancer risk, as well as excessive morbidity and mortality in cancer survivors.
Presented by: Catherine Marinac, PhD, Dana-Farber Cancer Institute, Boston
Written by Thenappan Chandrasekar, MD, clinical instructor, Thomas Jefferson University, twitter: @tchandra_uromd at the 19th Annual Society of Urological Oncology (SUO) 28-30 November 2018 - Phoenix, Arizona